2026 European Society of Cardiology (Munich)

Rishi Bansal-Proteomic changes during ANGPTL3 inhibition with vupanorsen in TRANSLATE-TIMI-70

Gaetano de Ferrari-Evolocumab and the Risk of a First Myocardial Infarction-A Pre-specified Analysis of the VESALIUS-CV Trial

Robert Giugliano-Effects of Evolocumab on Fatal Outcomes in Patients Without a Prior MI or Stroke-Pre-specified Analysis of the VESALIUS-CV Trial

Robert Giugliano-Long-term efficacy and safety of Olezarsen in patients with Severe Hypertriglyceridemia

Jose Nicolau-Reduction in Total Cardiovascular Events with Evolocumab in Patients with no Prior MI or Stroke-A Pre-specified Analysis of VESALIUS-CV

Eileen O’Meara-Natriuretic peptides in acute decompensated heart failure-Insights from the DAPA ACT HF-TIMI 68 Trial

Siddharth Patel-Effect of abelacimab vs. rivaroxaban on total bleeding events in patients with atrial fibrillation-an analysis from AZALEA–TIMI 71

Andre Small-Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure – A Prespecified Analysis of the DAPA ACT HF-TIMI 68 Trial

search previous next tag category expand menu location phone mail time cart zoom edit close